Gelofusine EP 0.070gm/0.038gm/0.85gm Injection

Welcome to the information page for Gelofusine EP 0.070gm/0.038gm/0.85gm Injection, brought to you by B Braun Medical Pvt Ltd. This product contains the active ingredient Calcium Chloride (0.070gm) + Potassium Chloride (0.038gm) + Sodium Chloride (0.85gm) and is indicated for Treatment of Cataract. Here, you can find crucial details, including its uses, pricing, and options to add it to your wishlist or compare it with similar medications.

MRP: ₹ 170
Packing: 500.0 ml in 1 vial
Salt Combination: Calcium Chloride (0.070gm) + Potassium Chloride (0.038gm) + Sodium Chloride (0.85gm)
Brand: B Braun Medical Pvt Ltd
Uses: Treatment of Cataract

Description

Gelofusine EP 0.070gm/0.038gm/0.85gm Injection is medicine used in pre- and postoperative cataract care
This medicine reduces discomfort, promotes optimal healing, and supports overall eye health
This way it improves your vision and helps you carry out your daily activities with less difficulties
Use Gelofusine EP 0.070gm/0.038gm/0.85gm Injection in the dose and duration as advised by the doctor
Wash your hands before using this medicine
It is advised to Check the label for directions before use of Gelofusine EP 0.070gm/0.038gm/0.85gm Injection
Use regularly and continue for as long as the doctor has prescribed the medicine.
Common side effects of this medicine include nausea, stomach upset, skin rash, and toxicity
If these symptoms persist for a longer duration or get worse, consult your doctor
In case of accidental contact with your ears, nose or mouth, rinse it thoroughly with clean water.
Inform your doctor if you are pregnant or breastfeeding or are allergic to this medicine or taking any other medication
It is advised not to drive or operate heavy machinery after use of this medicine in case you experience symptoms that can affect your ability to drive.

Cautions

Liver:	No interaction found/established
Kidney:	No interaction found/established
Driving:	UNSAFE: Gelofusine EP 0.070gm/0.038gm/0.85gm Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Breast feeding:	CONSULT YOUR DOCTOR: Information regarding the use of Gelofusine EP 0.070gm/0.038gm/0.85gm Injection during breastfeeding is not available. Please consult your doctor.
Pregnency:	CONSULT YOUR DOCTOR: Gelofusine EP 0.070gm/0.038gm/0.85gm Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Alcohol:	No interaction found/established
Drug Action:	N/A
Therapeutic class:	OPHTHAL
Habit Forming:	No
Chemical Class:	N/A

Uses of Gelofusine EP 0.070gm/0.038gm/0.85gm Injection

In Treatment of Cataract This medication helps keep the balance of fluids on the surface of the eye, supporting cell function and preventing infections
Additionally, it speeds up wound healing, minimizes inflammation, and contributes to tear film stability
This way it provides a comprehensive approach to pre- and post-cataract care.

Missed Doses

If you miss a dose of Gelofusine EP 0.070gm/0.038gm/0.85gm Injection, use it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

FAQs

Frequestly asked Questions

Side Effects

Common and Known Side effects of Gelofusine EP 0.070gm/0.038gm/0.85gm Injection

Nausea
Upset stomach
Skin rash

Reviews

Add your review

Alternate Medicines

Haemaccel Infusion

MRP: ₹ 562.02

Packing: 500.0 ml in 1 bottle

Salts: Calcium Chloride (0.070gm) + Potassium Chloride (0.038gm) + Sodium Chloride (0.85gm)

Brand: Abbott

Wishlist Add to cart